Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,044 | 6,429 | 8,935 | 11,318 | 6,381 |
| Marketable Securities | 191 | 209 | 331 | 304 | 1,915 |
| Other current assets | 0 | 0 | 50 | 50 | 50 |
| TOTAL | $13,429 | $6,726 | $9,507 | $11,863 | $8,535 |
| Non-Current Assets | |||||
| Investments And Advances | 33 | 33 | 387 | 387 | 410 |
| TOTAL | $33 | $33 | $387 | $387 | $410 |
| Total Assets | $13,462 | $6,759 | $9,895 | $12,250 | $8,945 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 783 | 695 | 931 | 679 | 700 |
| Accrued Expenses | 563 | 693 | 78 | 74 | 126 |
| TOTAL | $1,346 | $1,388 | $1,008 | $754 | $826 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 250 | 250 | 275 | 275 | 235 |
| TOTAL | $250 | $250 | $275 | $275 | $235 |
| Total Liabilities | $1,596 | $1,638 | $1,283 | $1,029 | $1,061 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,302 | 3,302 | 1,300 | 1,288 | 1,288 |
| Common Shares | 0 | 0 | 0 | 3 | 2 |
| Retained earnings | -47,283 | -45,099 | -41,621 | -38,976 | -36,299 |
| Other shareholders' equity | 27 | 22 | 50 | 28 | 14 |
| TOTAL | $11,866 | $5,122 | $8,611 | $11,222 | $7,885 |
| Total Liabilities And Equity | $13,462 | $6,759 | $9,895 | $12,251 | $8,945 |